FDA Import Refusal N90-0944251-4/70/1 — Purna Pharmaceuticals NV
The FDA refused shipment N90-0944251-4/70/1 from Purna Pharmaceuticals NV (Belgium) on Mar 23, 2017. The refused product falls under Drugs and Biologics — SPECTINOMYCIN DIHYDRO-CL PENTAHYDRATE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 23, 2017
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 56KCP80 SPECTINOMYCIN DIHYDRO-CL PENTAHYDRATE
- Charges
- 75